Late-Breaking Clinical Trials
Submission Deadline: 1 p.m. ET on Thursday, Nov. 10
The submission process for late-breaking clinical trials is now closed.
Plan to join us in New Orleans as presenters share their research and debate and discuss the outcomes with a panel of global thought-leaders.
Late-Breaking Clinical Trials were accepted across the following categories:
- Major Study
- Smaller Study/Randomized Clinical Trial
- Multi-center Observational Study or Registry
- Secondary Analysis of Major Clinical Trial
Accepted Late-Breaking Clinical Trial submissions will be presented during one of five LBCT sessions in the Main Tent in New Orleans and streamed live on the ACC.23/WCC virtual platform. Three LBCT sessions will be co-sponsored by the Journal of the American College of Cardiology (JACC), the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM). Each accepted submission will be considered for JACC Rapid Review and publication in JACC, JAMA and NEJM. In addition, each LBCT session will be followed by a press conference with top media outlets.
Submit your research by 1 p.m. ET on Thursday, Nov. 10 for a chance to present at ACC.23/WCC!